Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

GeneDx Hldgs Q1 2024 Adj EPS $(0.33) Beats $(0.67) Estimate, Sales $62.422M Beat $49.463M Estimate

Author: Benzinga Newsdesk | April 29, 2024 04:48pm
GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) by 50.75 percent. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.20 percent. This is a 44.70 percent increase over sales of $43.139 million the same period last year.

Posted In: WGS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist